Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

ClinicalTrials.gov ID: NCT06785454

Public ClinicalTrials.gov record NCT06785454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 10:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Crossover Study to Evaluate the Efficacy and Safety of Lorundrostat in Participants With Moderate to Severe Obstructive Sleep Apnea and Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of the study is to assess the effect of lorundrostat taken orally (po) once a day on the Apnea-Hypopnea Index (AHI) in participants with moderate to severe obstructive sleep apnea (OSA) and hypertension.

Study identification

NCT ID
NCT06785454
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mineralys Therapeutics Inc.
Industry
Enrollment
48 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2025
Primary completion
Dec 16, 2025
Completion
Dec 28, 2025
Last update posted
Aug 20, 2026

2025

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
The University of Alabama Tuscaloosa Alabama 35401
Chandler Clinical Trials Chandler Arizona 85224
Preferred Research Partners Inc. Little Rock Arkansas 72211
Orange County Research Institute Anaheim California 92801
The Neurology Center of Southern California - Profound Research, LLC Carlsbad California 92011
Probe Clinical Research Corporation Riverside California 92501
Research Carolina Elite Denver Colorado 28037
Nouvelle Clinical Research Cutler Bay Florida 33189
Arrow Clinical Trials Daytona Beach Florida 32117
PharmaDev Clinical Research Institute, LLC Miami Florida 33176
CNS Healthcare - Orlando (Clinical Neuroscience Solutions) Orlando Florida 32801
NeuroTrials Research Inc Atlanta Georgia 30328
Centricity Research Rincon Pulmonology Rincon Georgia 31326
Chicago Research Center Inc Chicago Illinois 60634
Centennial Medical Group Columbia Maryland 21045
Velocity Clinical Research, Rockville Rockville Maryland 20854
Henry Ford Health System/Henry Ford Medical Center - Columbus Novi Michigan 48377
Revive Research Institute, Inc Southfield Michigan 48075
Healthcare Research Network Hazelwood Missouri 63042
Clayton Sleep Institute St Louis Missouri 63123
Patient First MD Middletown New Jersey 07748
CTI Clinical Research Center Cincinnati Ohio 45212
Northwest Research Center Portland Oregon 97202
CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis) Memphis Tennessee 38119
Huntsville Research Institute LLC Huntsville Texas 77340
Sleep Therapy Research Center San Antonio Texas 78229
University of Washington Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06785454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06785454 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →